Plasma ICAM-1 levels were lower in T2DM groups when compared to control (control: 269.6 [184.2–335.3] vs. Group A: 197.8 [167.3–228.8], p <0.01, vs. group B: 204.1 [171.6–238.2], p <0.05 and vs. group C: 206.3 [165.4–228.3], p <0.05) (Table 2). This evidence concerns the gene ICAM1 and type 2 diabetes mellitus.